Recombinant CSF2RA (Mavrilimumab Biosimilar) antibody

Catalog No. ABIN7666197

The Human Monoclonal anti-CSF2RA (Mavrilimumab Biosimilar) antibody has been validated for . It is suitable to detect CSF2RA (Mavrilimumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CSF2RA (Mavrilimumab Biosimilar) antibody (ABIN7666197)

Target: CSF2RA (Mavrilimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CSF2RA (Mavrilimumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-CSF2RA (Mavrilimumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: CD116 antibody (Mavrilimumab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for CSF2RA (Mavrilimumab Biosimilar)

Target: CSF2RA (Mavrilimumab Biosimilar)

Alternative Name: Mavrilimumab biosimilar

Target Type: Biosimilar

Background: Mavrilimumab | CSF2RA

Gene ID: 1438

UniProt: P15509